Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia ; volume:14 ; number:1 ; day:3 ; month:5 ; year:2021 ; pages:1-11 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (3.5.2021), 1-11, 12.2021
- Creator
-
Dholaria, Bhagirathbhai
Labopin, Myriam
Sanz, Jaime
Ruggeri, Annalisa
Cornelissen, Jan
Labussière-Wallet, Hélène
Blaise, Didier
Forcade, Edouard
Chevallier, Patrice
Grassi, Anna
Zubarovskaya, Ludmila
Kuball, Jürgen
Ceballos, Patrice
Ciceri, Fabio
Baron, Frederic
Savani, Bipin N.
Nagler, Arnon
Mohty, Mohamad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01086-2
- URN
-
urn:nbn:de:101:1-2021090620283033056553
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dholaria, Bhagirathbhai
- Labopin, Myriam
- Sanz, Jaime
- Ruggeri, Annalisa
- Cornelissen, Jan
- Labussière-Wallet, Hélène
- Blaise, Didier
- Forcade, Edouard
- Chevallier, Patrice
- Grassi, Anna
- Zubarovskaya, Ludmila
- Kuball, Jürgen
- Ceballos, Patrice
- Ciceri, Fabio
- Baron, Frederic
- Savani, Bipin N.
- Nagler, Arnon
- Mohty, Mohamad
- SpringerLink (Online service)
Other Objects (12)
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
Outcomes of acute myelogenous leukemia patients undergoing haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: impact of total body irradiation versus chemotherapy-based myeloablative conditioning
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT
Impact of ABO-mismatching following HLA-mismatched unrelated donor hematopoietic stem cell transplantation for AML: a report from the ALWP of the EBMT
Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model
Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
Outcomes of acute myelogenous leukemia patients undergoing haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: impact of total body irradiation versus chemotherapy-based myeloablative conditioning
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT
Impact of ABO-mismatching following HLA-mismatched unrelated donor hematopoietic stem cell transplantation for AML: a report from the ALWP of the EBMT
Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model
Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
Outcomes of acute myelogenous leukemia patients undergoing haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: impact of total body irradiation versus chemotherapy-based myeloablative conditioning
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT
Impact of ABO-mismatching following HLA-mismatched unrelated donor hematopoietic stem cell transplantation for AML: a report from the ALWP of the EBMT
Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model